These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21413876)

  • 1. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
    Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D; Kurt E; Kurt H; Degirmenci I; Kuçukarabaci B; Metintas M; Kucuk MU; Gunes HV; Colak E
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.
    Bayram B; Sayin E; Erkasap N; Onlü H; Ozkurt M; Sahin F; Türkoğlu Z
    Rheumatol Int; 2012 Jan; 32(1):259-62. PubMed ID: 21240498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.
    Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
    J Assist Reprod Genet; 2007 Sep; 24(9):412-8. PubMed ID: 17661167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS).
    Bayram B; Kılıççı C; Onlü H; Ozkurt M; Erkasap N; Yıldırım E; Sahin F
    Gene; 2011 Dec; 489(2):86-8. PubMed ID: 21939743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
    Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
    J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 gene polymorphism in its promoter region with polycystic ovarian syndrome].
    Zhao JL; Chen ZJ; Zhao YR; Zhao LX; Wang LC; Tang R; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):528-31. PubMed ID: 16202290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population.
    Gunes HV; Cosan DT; Ata N; Birdane A; Ustuner MC; Dikmen M; Bayram B; Degirmenci I
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):303-5. PubMed ID: 20392162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
    Bayramoglu A; Gunes HV; Metintas M; Degirmenci I; Guler HI; Ustuner C; Musmul A
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):587-90. PubMed ID: 24955483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
    Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
    Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY; Ataç FB; Ogus E; Ozbek N
    Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor I 4G/5G polymorphism in neonatal respiratory distress syndrome.
    Armangil D; Yurdakök M; Okur H; Gürgey A
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):352-7. PubMed ID: 20460339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene on primary nephrotic syndrome.
    Luo Y; Wang C; Tu H
    Mol Med Rep; 2014 Mar; 9(3):894-8. PubMed ID: 24435552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.